USA - New York Stock Exchange - NYSE:MD - US58502B1061 - Common Stock
ChartMill assigns a Buy % Consensus number of 79% to MD. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | Truist Securities | Maintains | Hold -> Hold |
| 2025-11-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-05 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2025-08-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-12 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-08 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-04-11 | Truist Securities | Maintains | Hold -> Hold |
| 2025-02-21 | UBS | Maintains | Neutral -> Neutral |
| 2025-02-21 | Truist Securities | Maintains | Hold -> Hold |
| 2025-01-06 | Truist Securities | Maintains | Hold -> Hold |
| 2024-12-16 | Macquarie | Initiate | Outperform |
| 2024-11-19 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-11-05 | UBS | Maintains | Neutral -> Neutral |
| 2024-11-05 | Jefferies | Maintains | Buy -> Buy |
| 2024-11-04 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-11-04 | Deutsche Bank | Maintains | Hold -> Hold |
| 2024-11-04 | Truist Securities | Maintains | Hold -> Hold |
| 2024-10-07 | Truist Securities | Maintains | Hold -> Hold |
| 2024-09-26 | Jefferies | Upgrade | Hold -> Buy |
| 2024-08-15 | Truist Securities | Maintains | Hold -> Hold |
| 2024-08-09 | UBS | Maintains | Neutral -> Neutral |
| 2024-07-15 | Truist Securities | Maintains | Hold -> Hold |
| 2024-06-07 | Deutsche Bank | Upgrade | Sell -> Hold |
| 2024-05-15 | Truist Securities | Maintains | Hold -> Hold |
| 2024-03-06 | Jefferies | Maintains | Hold -> Hold |
| 2024-02-21 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-02-21 | Truist Securities | Maintains | Hold -> Hold |
| 2023-11-30 | UBS | Initiate | Neutral |
| 2023-10-11 | Truist Securities | Maintains | Hold -> Hold |
| 2023-05-09 | Truist Securities | Maintains | Hold |
15 analysts have analysed MD and the average price target is 23.12 USD. This implies a price increase of 2.62% is expected in the next year compared to the current price of 22.53.
The consensus rating for PEDIATRIX MEDICAL GROUP INC (MD) is 78.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.